ETFs › BBH

VanEck Biotech ETF (BBH)

healthcare biotechnology growth

Focusing on the cutting-edge field of biotechnology, this ETF provides exposure to companies developing innovative medical treatments and technologies. It offers a way to invest in potential breakthroughs in healthcare and pharmaceuticals. The fund's concentrated portfolio includes both established biotech giants and emerging players.

Key Info

AUM $467.28M
Expense Ratio 0.35%
Inception Date December 20, 2011
Distribution Frequency Annually
Weighting Method Modified Market Cap
Number of Holdings 25
Tracking Index MVIS US Listed Biotech 25 Index

See Also

XBI IBB ARKG

Last updated: September 10, 2024